Endo International plc reported that its net loss for the first-quarter ended March 31, 2023 narrowed to $3.28 million or $0.01 per share from $71.97 million or $0.
Actavis receives US approval for antidepressant drug | IceNews icenews.is - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from icenews.is Daily Mail and Mail on Sunday newspapers.